To date, at least five groups succeeded in reprogramming PTPN11-mutant patient-derived JMML cells to IPSCs, and then re-differentiating these into JMML-like cells [18,19,20,21,22]. The gene discussed is PTPN11; the disease is juvenile myelomonocytic leukemia.